Cite
HARVARD Citation
Higgins, P. et al. (n.d.). Efficacy and Safety of Upadacitinib as an Induction Therapy for Patients With Moderately‐to‐Severely Active Ulcerative Colitis: Combined Results From 382 Subjects in the Phase 2b Study U‐ACHIEVE. American journal of gastroenterology. p. . [Online].